Skip to main content
HQY $102.79 +0.45%
HQY logo

HQY · Healthequity, Inc.

Track HQY — free
$102.79 +0.46 (+0.45%) At close · Aug 18
Market Cap
$8.56B
Shares
83.60M
All earnings calls

Earnings call · FY2026 Q4

Healthequity, Inc. Q4 FY2026 Earnings Call

Healthequity, Inc. Q4 FY2026 Earnings Call

Concluded Mar 17, 2026 Audio replay
Mar 17, 2026 58:57 57 turns
Period
FY2026 Q4
Runtime
58:57
Sources
4 artifacts

Executive readout · one minute

What matters this quarter

HealthEquity reported fiscal Q4 with 23% adjusted EBITDA growth and 500+ bps of adjusted EBITDA margin expansion, added a record 553,000 new HSAs from sales in the quarter, and grew total HSA assets 14% to $36.5 billion. Management referenced a raised fiscal 2027 outlook in the CEO's intro, while the 8-K states the company reaffirmed its previously provided fiscal 2027 guidance.

Member Engagement Flywheel (Save/Spend/Invest) 98 HSA Growth and Record Sales 30 Marketplace Expansion 22 Profitability and Margin Expansion 18 Retail / ACA Distribution Channel 9 Security and Fraud Reduction 9

Management tone

Confident

Net tone +72 · low hedging

Grounding quotes
  • “Six was a year of accelerate as we delivered strong execution, significant margin expansion, and record HSA sales.”
  • “We're proud of the team's execution and the progress we're making building this platform for the long term.”
  • “We added over 1 million new HSAs from sales in a year when the U.S. economy added just 181,000 jobs. That is a powerful reflection of the demand for HSAs.”
  • “We're optimistic about the future as assets and engagement scales.”

Research coverage

4 live sources

Switch sources without leaving this page or losing your listening position.

Revenue · derived Q4 $334.59M +7.3% YoY
Gross margin · derived Q4 68.2% +7.6 pp YoY
Net income · derived Q4 $49.74M +88.7% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

Key takeaways

What improved, and what deserves a closer read.

Constructive signals

  • Q4 adjusted EBITDA grew 23% with more than 500 bps of adjusted EBITDA margin expansion.
  • Added a record 553,000 new HSAs from sales in Q4 (up 17% YoY) and over 1 million new HSAs from sales for the full year.
  • Total HSA assets grew 14% YoY to $36.5 billion, with HSA investments up 26% YoY to $18.5 billion and now more than 50% of total HSA assets.
  • Returned more than $300 million to shareholders via buybacks in fiscal 2026, reducing diluted shares outstanding by approximately 3%.
  • Fraud reimbursements in Q4 totaled approximately $0.3 million, an exit run rate of 0.1 basis points (well below the 1 basis point target); full-year fraud costs of approximately 1.1 basis points.
  • Total accounts reached 17.8 million; expanded into a new retail HSA enrollment channel targeting ACA exchange consumers.

Risks & pressure points

  • The 8-K reaffirms the previously provided fiscal 2027 outlook rather than confirming a raise, contradicting the CEO's intro framing of a 'raised fiscal 2027 outlook.'
  • Year-to-date new HSAs from sales were 1,040, flat versus the prior year.
  • HSA cash grew only 3% YoY to $17,982 million, lagging the 26% growth in HSA investments.
  • $4.5 billion of HSA cash is scheduled to reprice in fiscal 2027 at an average annualized yield of just 1.9%, a headwind to custodial cash revenue.
  • Net income growth (89% to $49.7 million) coincided with a 7% revenue increase, implying margin mix pressure on the topline.

Key moments

Jump directly to management's words in the synchronized transcript.

Quarter detail

How the reported period landed and where the business moved.

Capital returned

Buybacks · derived
$81.02M
Full-screen source Call document